ERBB2 and neoplasm: From the statistical analysis between the ERBB2 expression and clinicopathological parameters, we verified that ERBB2 RNAs levels are negatively correlated with the tumor malignancy grade and, that luminal A and HER2-positive FMT subtypes showed higher ERBB2 RNAs levels and triple negative FMT subtype the lowest.